Bristol-Myers Squibb Company vs Westpac Banking Corporation
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก ๋น๊ต
Bristol-Myers Squibb Company
$118.7B
์์ #149
Westpac Banking Corporation
$121.9B
์์ #144
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก
์ฃผ์ ์๊ฐ
- Westpac Banking Corporation์ด(๊ฐ) 2026๋ ๊น์ง Bristol-Myers Squibb Company์(๋ฅผ) ์ถ์ํ์ต๋๋ค
์ฐ๋๋ณ ๋น๊ต
| ์ฐ๋ | Bristol-Myers Squibb Company | Westpac Banking Corporation | ์ ๋ |
|---|---|---|---|
| 2026 | $118.7B | $121.9B | Westpac Banking Corporation |
| 2025 | $107.8B | $84.0B | Bristol-Myers Squibb Company |
| 2024 | $107.6B | $67.3B | Bristol-Myers Squibb Company |
| 2023 | $92.9B | $45.1B | Bristol-Myers Squibb Company |
| 2022 | $125.8B | $43.0B | Bristol-Myers Squibb Company |
| 2021 | $105.8B | $37.3B | Bristol-Myers Squibb Company |
| 2020 | $102.0B | $32.2B | Bristol-Myers Squibb Company |
| 2019 | $102.4B | $39.7B | Bristol-Myers Squibb Company |
| 2018 | $80.2B | $38.4B | Bristol-Myers Squibb Company |
| 2017 | $92.0B | $45.0B | Bristol-Myers Squibb Company |
| 2016 | $85.4B | $44.2B | Bristol-Myers Squibb Company |
| 2015 | $98.2B | $42.8B | Bristol-Myers Squibb Company |
| 2014 | $82.3B | $39.6B | Bristol-Myers Squibb Company |
| 2013 | $72.0B | $36.7B | Bristol-Myers Squibb Company |
| 2012 | $42.7B | $27.8B | Bristol-Myers Squibb Company |
| 2011 | $44.4B | $19.9B | Bristol-Myers Squibb Company |
| 2010 | $31.8B | $20.7B | Bristol-Myers Squibb Company |
| 2009 | $28.9B | $22.2B | Bristol-Myers Squibb Company |
| 2008 | $25.1B | $14.1B | Bristol-Myers Squibb Company |
| 2007 | $27.1B | $21.9B | Bristol-Myers Squibb Company |
| 2006 | $25.9B | $18.2B | Bristol-Myers Squibb Company |
| 2005 | $21.6B | $16.2B | Bristol-Myers Squibb Company |
| 2004 | $23.0B | $13.2B | Bristol-Myers Squibb Company |
| 2003 | $24.5B | $10.4B | Bristol-Myers Squibb Company |
| 2002 | $19.0B | $8.5B | Bristol-Myers Squibb Company |
| 2001 | $40.3B | $9.3B | Bristol-Myers Squibb Company |
| 2000 | $54.6B | $7.5B | Bristol-Myers Squibb Company |
| 1999 | $46.6B | $5.6B | Bristol-Myers Squibb Company |
| 1998 | $48.0B | $5.5B | Bristol-Myers Squibb Company |
| 1997 | $33.4B | $4.8B | Bristol-Myers Squibb Company |
| 1996 | $18.8B | $3.3B | Bristol-Myers Squibb Company |
| 1995 | $14.3B | $2.6B | Bristol-Myers Squibb Company |
| 1994 | $9.2B | $1.8B | Bristol-Myers Squibb Company |